Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.

Yang C, Nilsson L, Cheema MU, Wang Y, Frøkiær J, Gao S, Kjems J, Nørregaard R.

Theranostics. 2015 Jan 1;5(2):110-23. doi: 10.7150/thno.9717. eCollection 2015.

2.

Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials.

Kim JH, Jenrow KA, Brown SL.

Radiat Oncol J. 2014 Sep;32(3):103-15. doi: 10.3857/roj.2014.32.3.103. Epub 2014 Sep 30. Review.

3.

Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.

Gao S, Hein S, Dagnæs-Hansen F, Weyer K, Yang C, Nielsen R, Christensen EI, Fenton RA, Kjems J.

Theranostics. 2014 Aug 13;4(10):1039-51. doi: 10.7150/thno.7866. eCollection 2014.

4.

Chitosan hydrogel as siRNA vector for prolonged gene silencing.

Ma Z, Yang C, Song W, Wang Q, Kjems J, Gao S.

J Nanobiotechnology. 2014 Jun 19;12:23. doi: 10.1186/1477-3155-12-23.

5.

Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo.

Arany S, Benoit DS, Dewhurst S, Ovitt CE.

Mol Ther. 2013 Jun;21(6):1182-94. doi: 10.1038/mt.2013.42. Epub 2013 Mar 19.

6.

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles.

Ballarín-González B, Dagnaes-Hansen F, Fenton RA, Gao S, Hein S, Dong M, Kjems J, Howard KA.

Mol Ther Nucleic Acids. 2013 Mar 5;2:e76. doi: 10.1038/mtna.2013.2.

7.

Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells.

Novobrantseva TI, Borodovsky A, Wong J, Klebanov B, Zafari M, Yucius K, Querbes W, Ge P, Ruda VM, Milstein S, Speciner L, Duncan R, Barros S, Basha G, Cullis P, Akinc A, Donahoe JS, Narayanannair Jayaprakash K, Jayaraman M, Bogorad RL, Love K, Whitehead K, Levins C, Manoharan M, Swirski FK, Weissleder R, Langer R, Anderson DG, de Fougerolles A, Nahrendorf M, Koteliansky V.

Mol Ther Nucleic Acids. 2012 Jan 24;1:e4. doi: 10.1038/mtna.2011.3.

8.

Host responses in tissue repair and fibrosis.

Duffield JS, Lupher M, Thannickal VJ, Wynn TA.

Annu Rev Pathol. 2013 Jan 24;8:241-76. doi: 10.1146/annurev-pathol-020712-163930. Epub 2012 Oct 22. Review.

9.

Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Wynn TA, Ramalingam TR.

Nat Med. 2012 Jul 6;18(7):1028-40. doi: 10.1038/nm.2807. Review.

10.

Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Yong KT, Hui R, Prasad PN, Schwartz SA.

J Neuroimmune Pharmacol. 2012 Sep;7(3):673-85. doi: 10.1007/s11481-012-9379-7. Epub 2012 Jun 12.

11.

Progress toward in vivo use of siRNAs-II.

Rettig GR, Behlke MA.

Mol Ther. 2012 Mar;20(3):483-512. doi: 10.1038/mt.2011.263. Epub 2011 Dec 20. Review.

12.

Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo.

Lundberg P, Yang HJ, Jung SJ, Behlke MA, Rose SD, Cantin EM.

J Control Release. 2012 Jun 10;160(2):194-9. doi: 10.1016/j.jconrel.2011.10.034. Epub 2011 Nov 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk